Metabolism
Metabolism inhibitors are compounds that interfere with metabolic pathways, altering the production and utilization of energy within cells. These inhibitors are used to study the regulation of metabolism, the role of metabolic pathways in diseases like cancer and diabetes, and to develop new therapeutic strategies. Metabolism inhibitors can target various enzymes and processes involved in glycolysis, fatty acid oxidation, and other metabolic functions. At CymitQuimica, we offer a wide range of high-quality metabolism inhibitors to support your research in biochemistry, metabolic disorders, and drug development.
Subcategories of "Metabolism"
- AhR(41 products)
- Aminopeptidase(67 products)
- CETP(18 products)
- Carbonic Anhydrase(178 products)
- Casein Kinase(130 products)
- DHFR(33 products)
- Decarboxylase(4 products)
- Dehydrogenase(270 products)
- FAAH(64 products)
- FXR(58 products)
- Factor Xa(80 products)
- Fatty Acid Synthase(33 products)
- Ferroptosis(215 products)
- GR(3 products)
- GSNOR(3 products)
- Glucokinase(54 products)
- HIF/HIF Prolyl-Hydroxylase(142 products)
- HMG-CoA Reductase(33 products)
- Hydroxylase(30 products)
- IDO(82 products)
- LDL(8 products)
- Lipase(97 products)
- Lipid(59 products)
- Lipoxygenase(125 products)
- MAO(87 products)
- MPO(2 products)
- NAMPT(36 products)
- P450(6 products)
- PAI-1(25 products)
- PDE(166 products)
- PED(1 products)
- PKM(15 products)
- PPAR(164 products)
- Phospholipase(82 products)
- ROR(42 products)
- Retinoid Receptor(29 products)
- SGK(11 products)
- Thioredoxin(12 products)
- Transferase(30 products)
- Transporter(42 products)
- UGT(4 products)
- Xanthine Oxidase (XO) Inhibitors(9 products)
Show 34 more subcategories
Found 8625 products of "Metabolism"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
DSPE-PEG1000-F3
<p>DSPE-PEG1000-F3 is a PEG compound made from DSPE and a targeting peptide called nucleolin (F3). The F3 peptide can specifically bind to cell surface nucleolin, enabling efficient transport from the cell surface to the nucleus. DSPE-PEG1000-F3 is applicable in drug delivery.</p>Color and Shape:Odour SolidABC34
CAS:<p>ABC34, an inactive JJH260 control, poorly inhibits AIG1 enzyme at IC50 >25 μM; potently blocks off-target hydrolases ABHD6 and PPT1.</p>Formula:C31H33N5O6Color and Shape:SolidMolecular weight:571.634DSPE-PEG5000-CSTSMLKAC
<p>DSPE-PEG5000-CSTSMLKAC is a PEG compound consisting of DSPE and CSTSMLKAC. CSTSMLKAC facilitates targeted homing of phages to ischemic heart tissue. This compound can be utilized for drug delivery.</p>Color and Shape:Odour SolidDSPE-PEG2000-MPG
<p>DSPE-PEG2000-MPG is a PEG compound composed of DSPE and the peptide carrier (MPG). The MPG component is derived from the nuclear localization sequence (NLS) of the SV40 large T antigen and the fusion peptide domain of HIV-1gp41. It effectively delivers short oligonucleotides into cells independently of the endosomal pathway.</p>Color and Shape:Odour SolidNIM811
CAS:<p>NIM811 is an orally bioavailable dual inhibitor of mitochondrial permeability transition and cyclophilin.</p>Formula:C62H111N11O12Purity:98%Color and Shape:SolidMolecular weight:1202.635DSPE-PEG1000-KAA
<p>DSPE-PEG1000-KAA is a PEG compound comprised of DSPE and the CKAAKNK (KAA) peptide. The CKAAKNK peptide specifically binds to tumor vasculature in RIP-Tag2 transgenic mice. DSPE-PEG1000-KAA is applicable for drug delivery.</p>Color and Shape:Odour SolidGS-493
CAS:<p>GS-493: Specific SHP2 inhibitor, very potent (IC50=71 nM), 29x affinity vs. SHP1, 45x vs. PTP1B; hinders cancer cell growth/movement.</p>Formula:C21H14N6O8SColor and Shape:SolidMolecular weight:510.44CT140
<p>CT140 is a human IgG4 monoclonal antibody (mAb) that specifically targets PAI-1. The suggested isotype control for this compound is Human IgG4 kappa, Isotype Control.</p>Color and Shape:Odour LiquidDSPE-PEG3000-TAASGVRSMH
<p>DSPE-PEG3000-TAASGVRSMH is a PEG compound composed of DSPE and TAASGVRSMH. TAASGVRSMH exhibits a strong affinity for the NG2 proteoglycan on the PC membrane. DSPE-PEG3000-TAASGVRSMH can be utilized in drug delivery.</p>Color and Shape:Odour SolidDSPE-PEG3000-LyP-1
<p>DSPE-PEG3000-LyP-1 is a PEG compound composed of DSPE and a nine-residue peptide (LyP-1). The LyP-1 component specifically targets tumor-associated lymphatics and macrophages.</p>Color and Shape:Odour SolidDSPE-PEG5000-octreotide
<p>DSPE-PEG5000-Octreotide is a PEG compound composed of DSPE and Octreotide. Octreotide serves as a somatostatin receptor agonist and exhibits anti-tumor properties, induces apoptosis, and is applicable for acromegaly research. DSPE-PEG5000-Octreotide can be utilized in drug delivery.</p>Color and Shape:Odour SolidDSPE-PEG1000-K237
<p>DSPE-PEG1000-K237 is a PEG compound composed of DSPE and the KDR-targeting peptide (K237). K237 functionally disrupts the interaction between VEGF and KDR receptors, producing significant biological effects such as inhibiting angiogenesis and tumor growth. DSPE-PEG1000-K237 is applicable for drug delivery.</p>Color and Shape:Odour SolidDSPE-PEG5000-pPB
<p>DSPE-PEG5000-pPB is a PEG compound composed of DSPE and the cyclic oligopeptide (pPB). The pPB component has high binding affinity to PDGFRβ, which is overexpressed on activated hepatic stellate cells (HSC). DSPE-PEG5000-pPB is applicable for drug delivery.</p>Color and Shape:Odour SolidDSPE-PEG1000-SP94
<p>DSPE-PEG1000-SP94 is a PEG compound composed of DSPE and the cell-penetrating peptide (SP94). SP94 exhibits specific binding affinity to hepatocellular carcinoma (HCC) cells.</p>Color and Shape:Odour SolidDSPE-PEG2000-M2pep
<p>DSPE-PEG2000-M2pep is a PEG compound formed from DSPE and the M2-polarized macrophage-targeting peptide (M2pep). M2pep acts as a monovalent or multivalent ligand conjugated with pro-apoptotic peptides to specifically target M2 macrophages with toxic effects. DSPE-PEG2000-M2pep is applicable for drug delivery.</p>Color and Shape:Odour SolidSDUY817
<p>SDUY817 is a dual APN/NEP inhibitor with IC50 values of 0.29 μM for APN and 7.4 μM for NEP. It exhibits analgesic effects in a concentration- and time-dependent manner, making it a potential candidate for research in the field of neuropathic pain disorders.</p>Formula:C18H16IN3O3Color and Shape:SolidMolecular weight:449.24DSPE-PEG1000-TAASGVRSMH
<p>DSPE-PEG1000-TAASGVRSMH is a PEG compound composed of DSPE and TAASGVRSMH. The TAASGVRSMH sequence exhibits high affinity for the NG2 proteoglycan on PC membranes. DSPE-PEG1000-TAASGVRSMH is useful for drug delivery applications.</p>Color and Shape:Odour SolidDSPE-PEG1000-VIP
<p>DSPE-PEG1000-VIP is a PEG compound composed of DSPE and the vasoactive intestinal peptide (VIP). It can be utilized for drug delivery.</p>Color and Shape:Odour SolidEthyl 4-chloro-2-oxo-1,2-dihydroquinoline-3-carboxylate
CAS:<p>ethyl 4-chloro-2-oxo-1,2-dihydroquinoline-3-carboxylate inhibits NAD(P)H: quinone oxidoreductase 1.</p>Formula:C12H10ClNO3Purity:99.19%Color and Shape:SolidMolecular weight:251.67DSPE-PEG2000-CREKA
<p>DSPE-PEG3000-CREKA is a PEG compound composed of DSPE and the fibrin-targeting peptide (CREKA). The CREKA peptide targets tumor cells and tumor vasculature, exhibiting antitumor activity. DSPE-PEG3000-CREKA is useful in drug delivery applications.</p>Color and Shape:Odour Solid
